Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$330,980
+$126,050 QoQ
Shares Held
2,981
-40.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#212
of 299 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GROUP ONE TRADING LLC holds $113,695,832 across 200 Biotechnology names. RYTM ranks #49 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
203,915 | $14,280,167 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
261,443 | $10,198,891 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
272,609 | $6,564,424 | |
| 4 | ABSI |
Absci Corp
|
524,747 | $6,081,817 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
151,994 | $5,640,497 | |
| 6 | NKTR |
Nektar Therapeutics
|
70,371 | $4,912,599 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
85,040 | $4,638,081 | |
| 8 | ABVX |
Abivax S.A.
|
29,767 | $3,966,750 |
All Filings in RYTM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $330,980 | 2,981 | Shares | Sole | 2026-08-14 | |
| 2024-06-30 | $204,930 | 4,991 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $185,235 | 4,275 | Shares | Sole | 2024-05-10 | |
| 2021-12-31 | $2,405 | 241 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,147 | 241 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $19,070 | 974 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $63,724 | 2,996 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $12,070 | 406 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $11,420 | 527 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||